Inne

Antibody Science

Recombinant monoclonal antibody to CCR2. Plozalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2. Plozalizumab
https://www.creativebiolabs.net/Plozalizumab-67696.htm
Momencik, trwa przetwarzanie danych   loading-animation